Cycurion (NASDAQ: CYCU) delivered better-than-expected earnings per share and revenue figures for the second quarter, though top-line growth remained negative year-over-year. The company reported quarterly losses of $(0.41) per share, which beat the analyst consensus estimate of $(0.56) by 26.79%. This result marks a significant improvement from the $(4.42) per share loss recorded in the same period last year, representing a 90.72% decrease in losses.

Revenue performance also surpassed analyst expectations. The company logged quarterly sales of $3.757 million, beating the consensus estimate of $3.615 million by 3.93%. However, this figure reflects a 3.37% decline compared to the $3.888 million in sales generated during the same period last year.

What the Numbers Show

The divergence between the dramatic improvement in earnings per share and the slight contraction in revenue highlights a shift in cost structure or operational efficiency. While revenue fell modestly by 3.37% year-over-year, the loss per share narrowed significantly by 90.72%, dropping from $(4.42) to $(0.41). This suggests that the reduction in losses was driven more by expense management or non-operational factors rather than top-line growth, as sales did not expand to support the margin improvement.

The company’s ability to beat both EPS and sales estimates indicates stronger-than-anticipated operational execution for the quarter, despite the broader trend of declining revenue compared to the prior year period.

Cycurion, Inc. (NASDAQ: CYCU) has confirmed that its hearing before the Nasdaq Hearings Panel is scheduled for August 20, 2026, at 10:00 a.m. Eastern Time. The McLean, Virginia-based cybersecurity solutions provider issued the update on August 7, 2026, to clarify the status of its listing and address shareholder inquiries. Crucially, the company emphasized that its common stock has not been delisted and continues to trade on the Nasdaq Capital Market under the symbol "CYCU." This confirmation provides immediate clarity for investors regarding the continuity of trading while the regulatory review process proceeds.

The scheduling of the hearing serves as a procedural stay on the potential delisting action, to the extent permitted by Nasdaq Listing Rules. This stay remains in effect pending the Panel’s final written decision. Cycurion noted that the hearing itself is a proceeding before the Panel and does not constitute the issuance of a final decision. The timing of the Panel’s final written decision is determined solely by the Panel, and the company does not expect to receive it on the date of the hearing.

Kevin Kelly, Chairman and Chief Executive Officer of Cycurion, stated that the company remains focused on executing its business plan and addressing the Nasdaq process. Kelly highlighted that the clarification was provided in response to shareholder inquiries, underscoring the company’s commitment to transparency. He affirmed that Cycurion will keep investors informed of material developments as they occur and expressed appreciation for the continued support of shareholders.

The company outlined its disclosure obligations regarding the outcome of the hearing. Cycurion committed to promptly disclosing the Panel’s decision and any other material developments as appropriate and in accordance with applicable disclosure requirements. This approach aligns with standard corporate governance practices for companies undergoing exchange compliance reviews.

Regulatory Context and Forward-Looking Statements

The press release included standard forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These statements relate to the operations and prospective growth of Cycurion’s business, including the scheduling and timing of the hearing, the anticipated timing of the Panel’s decision, and the outcome of that hearing. The company also referenced risks related to its ability to regain and maintain compliance with Nasdaq’s continued listing requirements and the continued listing and trading of its common stock.

Cycurion cautioned that forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include the outcome and timing of the Panel’s decision, which is outside the company’s control, and the possibility that the Panel may determine to delist the company’s securities. Additional factors are detailed in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed with the U.S. Securities and Exchange Commission.

Company Profile

Cycurion describes itself as a leading AI-driven, tech-enabled cybersecurity solutions provider. The company specializes in cybersecurity, program management, and business continuity, harnessing its AI-enhanced ARx platform and expert team to empower clients. Along with its subsidiaries — Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc. — Cycurion serves government, healthcare, and corporate clients committed to securing the digital future.